Cargando…

Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico

BACKGROUND: With the widespread transmission of the Omicron SARS-CoV-2 variant, reinfections have become increasingly common. Here, we explored the role of immunity, primary infection severity, and variant predominance in the risk of reinfection and severe COVID-19 during Omicron predominance in Mex...

Descripción completa

Detalles Bibliográficos
Autores principales: Montes-González, José Antonio, Zaragoza-Jiménez, Christian Arturo, Antonio-Villa, Neftali Eduardo, Fermín-Martínez, Carlos A., Ramírez-García, Daniel, Vargas-Vázquez, Arsenio, Gutiérrez-Vargas, Rosaura Idania, García-Rodríguez, Gabriel, López-Gatell, Hugo, Valdés-Ferrer, Sergio Iván, Bello-Chavolla, Omar Yaxmehen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110947/
https://www.ncbi.nlm.nih.gov/pubmed/37081954
http://dx.doi.org/10.3389/fpubh.2023.1146059
_version_ 1785027354242842624
author Montes-González, José Antonio
Zaragoza-Jiménez, Christian Arturo
Antonio-Villa, Neftali Eduardo
Fermín-Martínez, Carlos A.
Ramírez-García, Daniel
Vargas-Vázquez, Arsenio
Gutiérrez-Vargas, Rosaura Idania
García-Rodríguez, Gabriel
López-Gatell, Hugo
Valdés-Ferrer, Sergio Iván
Bello-Chavolla, Omar Yaxmehen
author_facet Montes-González, José Antonio
Zaragoza-Jiménez, Christian Arturo
Antonio-Villa, Neftali Eduardo
Fermín-Martínez, Carlos A.
Ramírez-García, Daniel
Vargas-Vázquez, Arsenio
Gutiérrez-Vargas, Rosaura Idania
García-Rodríguez, Gabriel
López-Gatell, Hugo
Valdés-Ferrer, Sergio Iván
Bello-Chavolla, Omar Yaxmehen
author_sort Montes-González, José Antonio
collection PubMed
description BACKGROUND: With the widespread transmission of the Omicron SARS-CoV-2 variant, reinfections have become increasingly common. Here, we explored the role of immunity, primary infection severity, and variant predominance in the risk of reinfection and severe COVID-19 during Omicron predominance in Mexico. METHODS: We analyzed reinfections in Mexico in individuals with a primary infection separated by at least 90 days from reinfection using a national surveillance registry of SARS-CoV-2 cases from March 3rd, 2020, to August 13th, 2022. Immunity-generating events included primary infection, partial or complete vaccination, and booster vaccines. Reinfections were matched by age and sex with controls with primary SARS-CoV-2 infection and negative RT-PCR or antigen test at least 90 days after primary infection to explore reinfection and severe disease risk factors. We also compared the protective efficacy of heterologous and homologous vaccine boosters against reinfection. RESULTS: We detected 231,202 SARS-CoV-2 reinfections in Mexico, most occurring in unvaccinated individuals (41.55%). Over 207,623 reinfections occurred during periods of Omicron (89.8%), BA.1 (36.74%), and BA.5 (33.67%) subvariant predominance and a case-fatality rate of 0.22%. Vaccination protected against reinfection, without significant influence of the order of immunity-generating events and provided >90% protection against severe reinfections. Heterologous booster schedules were associated with ~11% and ~ 54% lower risk for reinfection and reinfection-associated severe COVID-19, respectively, modified by time-elapsed since the last immunity-generating event, when compared against complete primary schedules. CONCLUSION: SARS-CoV-2 reinfections increased during Omicron predominance. Hybrid immunity provides protection against reinfection and associated severe COVID-19, with potential benefit from heterologous booster schedules.
format Online
Article
Text
id pubmed-10110947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101109472023-04-19 Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico Montes-González, José Antonio Zaragoza-Jiménez, Christian Arturo Antonio-Villa, Neftali Eduardo Fermín-Martínez, Carlos A. Ramírez-García, Daniel Vargas-Vázquez, Arsenio Gutiérrez-Vargas, Rosaura Idania García-Rodríguez, Gabriel López-Gatell, Hugo Valdés-Ferrer, Sergio Iván Bello-Chavolla, Omar Yaxmehen Front Public Health Public Health BACKGROUND: With the widespread transmission of the Omicron SARS-CoV-2 variant, reinfections have become increasingly common. Here, we explored the role of immunity, primary infection severity, and variant predominance in the risk of reinfection and severe COVID-19 during Omicron predominance in Mexico. METHODS: We analyzed reinfections in Mexico in individuals with a primary infection separated by at least 90 days from reinfection using a national surveillance registry of SARS-CoV-2 cases from March 3rd, 2020, to August 13th, 2022. Immunity-generating events included primary infection, partial or complete vaccination, and booster vaccines. Reinfections were matched by age and sex with controls with primary SARS-CoV-2 infection and negative RT-PCR or antigen test at least 90 days after primary infection to explore reinfection and severe disease risk factors. We also compared the protective efficacy of heterologous and homologous vaccine boosters against reinfection. RESULTS: We detected 231,202 SARS-CoV-2 reinfections in Mexico, most occurring in unvaccinated individuals (41.55%). Over 207,623 reinfections occurred during periods of Omicron (89.8%), BA.1 (36.74%), and BA.5 (33.67%) subvariant predominance and a case-fatality rate of 0.22%. Vaccination protected against reinfection, without significant influence of the order of immunity-generating events and provided >90% protection against severe reinfections. Heterologous booster schedules were associated with ~11% and ~ 54% lower risk for reinfection and reinfection-associated severe COVID-19, respectively, modified by time-elapsed since the last immunity-generating event, when compared against complete primary schedules. CONCLUSION: SARS-CoV-2 reinfections increased during Omicron predominance. Hybrid immunity provides protection against reinfection and associated severe COVID-19, with potential benefit from heterologous booster schedules. Frontiers Media S.A. 2023-04-04 /pmc/articles/PMC10110947/ /pubmed/37081954 http://dx.doi.org/10.3389/fpubh.2023.1146059 Text en Copyright © 2023 Montes-González, Zaragoza-Jiménez, Antonio-Villa, Fermín-Martínez, Ramírez-García, Vargas-Vázquez, Gutiérrez-Vargas, García-Rodríguez, López-Gatell, Valdés-Ferrer and Bello-Chavolla. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Montes-González, José Antonio
Zaragoza-Jiménez, Christian Arturo
Antonio-Villa, Neftali Eduardo
Fermín-Martínez, Carlos A.
Ramírez-García, Daniel
Vargas-Vázquez, Arsenio
Gutiérrez-Vargas, Rosaura Idania
García-Rodríguez, Gabriel
López-Gatell, Hugo
Valdés-Ferrer, Sergio Iván
Bello-Chavolla, Omar Yaxmehen
Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
title Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
title_full Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
title_fullStr Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
title_full_unstemmed Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
title_short Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
title_sort protection of hybrid immunity against sars-cov-2 reinfection and severe covid-19 during periods of omicron variant predominance in mexico
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110947/
https://www.ncbi.nlm.nih.gov/pubmed/37081954
http://dx.doi.org/10.3389/fpubh.2023.1146059
work_keys_str_mv AT montesgonzalezjoseantonio protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT zaragozajimenezchristianarturo protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT antoniovillaneftalieduardo protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT ferminmartinezcarlosa protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT ramirezgarciadaniel protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT vargasvazquezarsenio protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT gutierrezvargasrosauraidania protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT garciarodriguezgabriel protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT lopezgatellhugo protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT valdesferrersergioivan protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico
AT bellochavollaomaryaxmehen protectionofhybridimmunityagainstsarscov2reinfectionandseverecovid19duringperiodsofomicronvariantpredominanceinmexico